RHD*01N.03 - RHD*D-CE(2-9)-D
(ISBT table: RHD negative v4.0)
RHD*01N.04 - RHD*D-CE(3-9)-D
(ISBT table: RHD negative v4.0)

This entry is an hybrid RHD allele.

D-Chinese-1, RHD(1)-CE(3-9)-D(10), RHD*D-CE(2-9)-D, RHD*D-CE(2-9)-D (RHD*01N.03, RHD*01N.04), RHD-RHCe(2-9)-RHD, RHD-Rhce(3-9)-RHD,
Download VCF file

Molecular data

Nucleotides: 361T>A; 380T>C; 383A>G; 455A>C; 505A>C; 509T>G; 514A>T; 544T>A; 577G>A; 594A>T; 602C>G; 667T>G; 697G>C; 712G>A; 733G>C; 744C>T; 787G>A; 800A>T; 916G>A; 932A>G; 941G>T; 968C>A; 974G>T; 979A>G; 985GG>CA deletion-insertion; 989A>C; 992A>T; 1025T>C; 1048G>C; 1053C>T; 1057GGA>TGG deletion-insertion; 1060GC>AA deletion-insertion; 1170T>C; 1193A>T;

Amino acids: L121M; V127A; D128G; N152T; M169L; M170R; I172F; S182T; E193K; K198N; T201R; F223V; E233Q; V238M; V245L; S248S; G263R; K267M; V306I; Y311C; G314V; P323H; S325I; I327V; G329H; Y330S; N331I; I342T; D350H; T351T; G353W; A354N; L390L; E398V;

Hybrid allele encompassing at least one RHCE exon: RHD-RHCE(2-9)-RHD , RHD-RHCE(3-9)-RHD,

Comments on the molecular basis:

  • in many cases studies do not or cannot distinguish RHD-RHCE(2-9)-RHD or RHD-RHCE(3-9)-RHD, thus data for ISBT alleles RHD*01N.03 and RHD*01N.04 are grouped; when seperated they are distinguished by RHD- or RHCE- specific polymorphisms in intron 1
  • recombination occurred whithin the 4.2kb homologous region between RHD-specific sequence in Intron 1 and RHC-specific sequence in Intron 2, exon 2 could be RhD or RhC
  • see also "Additional comments" section on the RhesusBase http://www.rhesusbase.info/RHDRHD-RHCe(2-9)-RHD.htm
  • PCR-RFLP pattern and sequencing of exons 1 and 10; the origin of exon 2 could not be determined
  • one sample tested positive for an RHD Intron 2–specific polymorphism and was assigned to RHD(1-2)-CE(3-9)-D(10)
  • hybrid structure was deduced from the PCR pattern
  • listed as RHD- CE(2-9)-D; see text for more details regarding possible breakpoint and the study regarding the origin of Exon 2; no evidence for the suballelic versions proposed in 11495631
  • NGS
  • Figure 2

Extracellular position of one or more amino acid substitutions:

  • hybrid RHD-RHCE, several residues are predicted to be extracellular

Splicing:

Unconventional prediction methods:

Phenotype

Main D phenotype: D negative (DEL excluded) (last update: Aug. 9, 2020)
Reports by D phenotype
  • DEL
    • adsorption-elution was performed, 1 sample
  • D negative
    • adsorption-elution was performed
    • adsorption-elution was not performed
    • adsorption-elution was performed, results not completely clear
    • adsorption-elution was performed
    • adsorption-elution was not performed
    • adsorption-elution was performed
    • adsorption-elution was not performed
    • adsorption-elution was performed
    • adsorption-elution was performed
    • adsorption-elution was not performed
    • adsorption-elution was performed
    • article states that adsorption-elution was performed but results of this method are not clear
    • adsorption-elution was performed
    • adsorption-elution was performed
    • adsorption-elution was not performed
    • study may overlap with 24679597
    • study may overlap with 24656493; adsorption-elution was not performed
    • ISBT classification
    • adsorption-elution was performed on at least one sample
    • initially typed as D negative, adsorption-elution was performed but results not clear
    • adsorption-elution was not performed
    • adsorption-elution was performed
    • adsorption-elution was performed
    • adsorption-elution was not performed
    • adsorption-elution was not performed
    • adsorption-elution was not performed
    • including by IAT; adsorption-elution was not performed
    • adsorption-elution was not performed, same sample as in 9716619
    • adsorption-elution was not performed
    • adsorption-elution was not performed
    • adsorption-elution was not performed
    • adsorption-elution was not performed
Other RH phenotypes: RH:-2, -3, -4,
  • RH:-2 inferred from the reported RHCE phenotypes of the carriers
  • RH:-3 inferred from the reported RHCE phenotypes of the carriers
  • RH:-4 inferred from the reported RHCE phenotypes of the carriers
Serology with monoclonal anti-D
  • 21 anti-D tested, results not detailed
  • some anti-D tested, results not detailed; "Besides the investigation of D and RHD, we also examined all RBCs with anti-CD47, anti-CD241, and anti-LW by flow cytometry and found no significant differences in expression level compared to control RBCs (data not shown)"
  • negative, with a panel of 10 monoclonal anti-D
Antigen Density (Ag/RBC)
  • 0 (below the limit of detection) Ag/RBC, 3 samples
More phenotype data
Rhesus Similarity Index

Haplotype

Main CcEe phenotype association: Ce is the most frequent association, ce is less frequent (last update: July 28, 2020)
Number of samples reported by haplotype
ce Ce cE CE
ce 60 407 5 0
Ce 26 57 1
cE 0 0
CE 0
Reports by CcEe phenotype
  • with Ce
    • 1 sample (same sample as 7912557, not counted twice) (study may overlap with 24656493)
    7 samples (including 3 homozygous)
    12 samples
    6 samples (1 homozygous)
  • with ce
    • 56 samples
    1 sample
    3 samples
  • with Ccee
    • 10 samples (study may overlap with 24679597)
    29 samples (study may overlap with 24656493)
    1 sample
    11 samples
    39 samples
    91 samples
    17 samples
    9 samples
    22 samples
    2 samples
    23 samples (some samples may overlap with 19392776)
    57 samples
    3 samples
    67 samples (some samples may overlap with 17348873)
    13 samples (11 samples listed as RHD-CE(2-9)-D, 1 sample listed as RHD-CE(3-9)-D, 1 sample listed as RHD-CE(3-9)-D-Innsbruck)
    5 samples
    8 samples
  • with ccEe
    • 4 samples
    1 sample
  • with CcEe
    • 5 samples
    3 samples (in trans with RHef00283)
    1 sample
    40 samples
    2 samples (some samples may overlap with 19392776)
    6 samples (some samples may overlap with 17348873)
  • with CCEe
    • 1 sample
Main allele association:
Reports by allele association
  • RHCE*ceEK or RHCE*ce
    • 1 sample
  • RHCE*01 or RHCE*02
    • 1 sample
  • RHCE*Ce or RHCE*ceVS.02
    • 1 sample

Alloimmunization

Antibodies in carriers
Antibody specificity: D (RH1)
Summary: D negative, at risk for anti-D (last update: Aug. 25, 2020)
Detailed information
Antibodies in D negative recipients

Alloimmunization in recipients: expected to be possible, see phenotype data

Reports

Summary: common allele, in D negative individuals mainly of European and Eastern Asian descent, or compatible with such descent (last update: Aug. 9, 2020)
Detailed reports
  • 1/28 samples donors with D negative phenotype White, in the Australian population
  • 1 sample Black
  • 11/8442 (3 with RHD-specific and 8 with RHCE-specific polymorphisms in intron 1) 8442 donors with D negative phenotype, screened for presence of the RHD gene in two surveys; 754 donors were C and/or E positive, the rest were ccee phenotype; 5 donors were revealed to be weakly D positive in the German population, Baden-Wurttemberg
  • 8/102 102 samples with D negative phenoype by IAT (118 D negative among 41.921 first time donors, DNA was available for 95; 7 D negative pregnant women), 76 were true D negative and 26 DEL phenotypes in the Chinese population (Shenzen area, 96% Chinese Han)
  • 13/204 donors with D negative phenotype Taiwanese
  • 4/74 (+1 not fully typed but assumed) donors with D negative phenotype (adsorption-elution was not performed) Chinese Han
  • 23/264 samples (or 23/528 alleles) (1 listed as RHD-CE(2-9)-D1, all others as RHD-CE(2-9)-D2) donors with D negative phenotype Korean
  • 29/738 samples with D negative, but C and/or E positive phenotype, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the Austrian population, Tyrol
  • 1/104 samples with D negative, but C and/or E positive phenotype, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the Swiss population, Bern and the canton of Bern
  • 4/333 samples with D negative, but C and/or E positive phenotype, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the Slovenian population
  • 3/400 samples with D negative, but C and/or E positive phenotype, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the German (states of Lower Saxony, Saxony- Anhalt, Thuringia, Oldenburg, and Bremen) population
  • 2/54 samples with D negative, but C and/or E positive phenotype, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the German (city of Braunschweig and eastern parts of Lower Saxony) population
  • 0/71 samples with D negative, but C and/or E positive phenotype, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the Russian (Kirov Oblast) population
  • 1/126 donors with D negative phenotype Korean, South Korea
  • 26/163 donors with D negative phenotype in the Chinese population, reported by a lab from Shanghai
  • 1/2012 2012 serologicaly D negative mothers, fetal genotyping showed some RHD gene in 26 in Portuguese population
  • 2/23330 donor samples with D negative phenotype tested for RHD exons 4, 7 and 10 (94 were PCR positive, 74 weak D or DEL in subsequent serologic analysis) in the Austrian population, Upper Austria
  • 11/23330 samples of donors with D negative phenotype, tested for RHD exons 4, 7 and 10 (94 were PCR positive, 74 weak D or DEL in subsequent serologic analysis) in the Austrian population, Upper Austria
  • 84/733 donors with D negative phenotype Chinese (Shanghai)
  • 1/1644 among donors with D negative phenotype, tested for RHD exons Danish (Copenhagen area)
  • 1/239 among 2007 unrelated donors, 239 had D negative phenotype and were tested for RHD Intron 4 and Exon 10 in the Brazilian population (Sao Paulo, mainly racially mixed non-white skin color individuals)
  • 1/101 among 2450 donors with D negative phenotype, tested for RHD specific polymorphisms (101 were positive for the polymorphisms) Brazilian, Southeast and Northeast Brazil
  • 17/31200 consecutive donors with D negative phenotype, tested for presence of RHD intron 4, exon 7 and/or exon 10 in the Polish population
  • 163/2493 donors with apparent D negative phenotype (108/2493 were in fact weak D or DEL) Han Chinese (Shanxi Province, Central China)
  • 7/26243 donors with D negative phenotype in three studies with different inclusion criteria in the Swiss population, Zurich and Bern (study may overlap with 24679597)
  • 3/26243 donors with D negative phenotype in three studies with different inclusion criteria in the Swiss population (Zurich and Berne) (study may overlap with 24679597)
  • 28/25370 donors with D negative phenotype, screened for RHD exons 3 or 7, plus 5 and 10 in the Swiss population (study may overlap with 24656493)
  • 3/25370 donors with D negative phenotype screened for RHD exons 3 or 7, plus 5 and 10 in the Swiss population (study may overlap with 24656493)
  • 2/1314 samples with apparent D negative phenotype White Argentineans
  • 1/2027 2027 donors with D positive phenotyope, C and/or E positive, screened for RHD exons 4, 5 and 10 and for DEL phenotype in the Australian population
  • 103/3526 donors with D negative phenotype Japanese
  • 1 or more/37782 (heterozygous with RHef00447 because allele was not detected by the assay) 270 women with variant alleles among 37782 women with D negative phenotype, tested by quantitative fetal RHD genotyping designed to detect RHD exons 5 and 7 in the Dutch population
  • 1 sample non invasive fetal RHD detection study in the Argentinean population (Rosario)
  • 26/200 (18 hemizygous, 4 homozygous, 5 heterozygous) donors with D negative phenotype, tested by MPLA Chinese, Southern Han
  • 2/200 (heterozygous with RHef00442) donors with D positive phenotype, tested by MPLA Chinese, Southern Han
  • 1/662 among 662 pregnant patients with apparent D negative phenotype, enroled for fetal genotyping Caucasian, in the Australian population
  • 29/171 (28 hemizygous + 1 heterozygous with RHD(702delG)) donors with D negative phenotype, C and/or E positive Indian
  • 1/1174 donors with D negative phenotype United States population (Los Angeles)
  • 1/61 donors with apparent D negative phenotype, with C and/or E positive Serbia
  • 9/526 among donors with D negative phenotype, C and/or E positive, tested for presence of the RHD gene in the Argentinean population (Northwestern Argentina)
  • 9/117 (7 hemizygous, 2 homozygous) among 132479 donors screened, 117 had D negative phenotype in the northeastern Chinese population, Liaoning
  • 23/200 donors with D negative phenotype (DEL phenotype excluded) Thai
  • 2/121 (including 1 heterozygous with RHef00283) donors with DEL phenotype Thai
  • 5/129 (in trans with various alleles) donors with weak D phenotype Thai
  • 1 sample (heterozygous with RHef00772) RH:–1,w2 donor African American
  • 2/75 RH:–1,–4 or RH:–1,–5 donors reported by a French lab
  • 8/185 RH:–1,–4 or RH:–1,–5 recipients reported by a French lab
  • 8/310 (6 samples listed as RHD*Ce(3-9), 2 as RHD*Ce(361A,3-9) ) donors with D negative phenotype, C and/or E positive in the Italian population
  • 3/3147 3147 D negative samples screened for RHD intron 3/intron 4, exon 7 and 3'UTR specific sequences, 36 were positive in Portuguese population, mainly central Portugal
  • 4/274 donor with D negative phenotype Spanish
  • 11/6523 D negative donors underwent molecular screening for RHD exons 7 and 10 (RHD sequences were detected in 23/6523) in the Croatian population
  • 1 hemizygote listed as RHD*01N.03, 1 heterozygote listed as RHD*01N.04, 1 heterozygote listed as RHD*D−CE(2−9)−D among 278 samples selected for the development of nonspecific quantitative next-generation sequencing. (non-random samples, may have been reported in other studies)
Allele or phenotype frequency
  • 1/15152 (CI: 1/5610 - 1/55568) for allele with RHD-specific polymorphisms in intron 1 estimated allele frequency by testing 8442 donors with D negative phenotype, screened for presence of the RHD gene in two surveys; 754 donors were C and/or E positive, the rest were ccee phenotype; 5 donors were revealed to be weakly D positive in the German population (Baden-Wurttemberg)
  • 1/5682 (CI: 1/3046 - 1/13837) for allele with RHCE-specific polymorphisms in intron 1 estimated allele frequency by testing 8442 donors with D negative phenotype, screened for presence of the RHD gene in two surveys; 754 donors were C and/or E positive, the rest were ccee phenotype; 5 donors were revealed to be weakly D positive in the German population (Baden-Wurttemberg)
  • 0.002081 estimated allele frequency in population in the Chinese population (Shenzen area, 96% Chinese Han)
  • 0.039216 estimated allele frequency in individuals with D negative phenotype in the Chinese population (Shenzen area, 96% Chinese Han)
  • 0.034 calculated allele frequency in donors with D negative phenotype (adsorption-elution was not performed) Chinese Han
  • 1/4817 (CI: 1/784 - 1/17663) estimated allele frequency in samples with D negative phenotype but C and/or E positive, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the German (states of Lower Saxony, Saxony- Anhalt, Thuringia, Oldenburg, and Bremen) population
  • 1/640 (CI: 1/453 - 1/974) estimated allele frequency in samples with D negative phenotype but C and/or E positive, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the Austrian (state of Tyrol) population
  • 1/1911 (CI: 1/796 - 1/5594) estimated allele frequency in samples with D negative phenotype but C and/or E positive, screened for RHD specific sequences (in the 5'UTR region, exon 3 and exon 10) in the Slovenian population
  • 0.0798 calculated allele frequency in donors with D negative phenotype in the Chinese population, reported by a lab from Shanghai
  • 1/2120 (CI: 1/1282 - 1/3788) estimated allele frequency in individuals with D negative phenotype in the Austrian population, Upper Austria
  • 1/11665 (CI: 1/3704 - 1/66667) estimated allele frequency in individuals with D negative phenotype in the Austrian population, Upper Austria
  • 5.93 calculated allele frequency in individuals with D negative phenotype in the Chinese population (Shanghai)
  • 1/1835 (CI: 1/1714 - 1/5058) estimated allele frequency in individuals with D negative phenotype in the Polish population
  • 0,00287 calculated allele frequency in the northeastern Chinese Liaoning Province population
  • 1/58 calculated allele frequency among donors with D negative and C and/or E positive phenotype in the Croatian population
  • 1/593 calculated allele frequency among donors with D negative phenotype in the Croatian population

2D diagram

generated using Protter extraintra Met1 Met1 Ser2 Ser2 Ser3 Ser3 Lys4 Lys4 Tyr5 Tyr5 Pro6 Pro6 Arg7 Arg7 Ser8 Ser8 Val9 Val9 Arg10 Arg10 10Arg11 Arg11 Cys12 Cys12 Leu13 Leu13 Pro14 Pro14 Leu15 Leu15 Trp16 Trp16 Ala17 Ala17 Leu18 Leu18 Thr19 Thr19 Leu20 Leu20 20Glu21 Glu21 Ala22 Ala22 Ala23 Ala23 Leu24 Leu24 Ile25 Ile25 Leu26 Leu26 Leu27 Leu27 Phe28 Phe28 Tyr29 Tyr29 Phe30 Phe30 30Phe31 Phe31 Thr32 Thr32 His33 His33 Tyr34 Tyr34 Asp35 Asp35 Ala36 Ala36 Ser37 Ser37 Leu38 Leu38 Glu39 Glu39 Asp40 Asp40 40Gln41 Gln41 Lys42 Lys42 Gly43 Gly43 Leu44 Leu44 Val45 Val45 Ala46 Ala46 Ser47 Ser47 Tyr48 Tyr48 Gln49 Gln49 Val50 Val50 50Gly51 Gly51 Gln52 Gln52 Asp53 Asp53 Leu54 Leu54 Thr55 Thr55 Val56 Val56 Met57 Met57 Ala58 Ala58 Ala59 Ala59 Ile60 Ile60 60Gly61 Gly61 Leu62 Leu62 Gly63 Gly63 Phe64 Phe64 Leu65 Leu65 Thr66 Thr66 Ser67 Ser67 Ser68 Ser68 Phe69 Phe69 Arg70 Arg70 70Arg71 Arg71 His72 His72 Ser73 Ser73 Trp74 Trp74 Ser75 Ser75 Ser76 Ser76 Val77 Val77 Ala78 Ala78 Phe79 Phe79 Asn80 Asn80 80Leu81 Leu81 Phe82 Phe82 Met83 Met83 Leu84 Leu84 Ala85 Ala85 Leu86 Leu86 Gly87 Gly87 Val88 Val88 Gln89 Gln89 Trp90 Trp90 90Ala91 Ala91 Ile92 Ile92 Leu93 Leu93 Leu94 Leu94 Asp95 Asp95 Gly96 Gly96 Phe97 Phe97 Leu98 Leu98 Ser99 Ser99 Gln100 Gln100 100Phe101 Phe101 Pro102 Pro102 Ser103 Ser103 Gly104 Gly104 Lys105 Lys105 Val106 Val106 Val107 Val107 Ile108 Ile108 Thr109 Thr109 Leu110 Leu110 110Phe111 Phe111 Ser112 Ser112 Ile113 Ile113 Arg114 Arg114 Leu115 Leu115 Ala116 Ala116 Thr117 Thr117 Met118 Met118 Ser119 Ser119 Ala120 Ala120 120Leu121 Leu121 Ser122 Ser122 Val123 Val123 Leu124 Leu124 Ile125 Ile125 Ser126 Ser126 Val127 Val127 Asp128 Asp128 Ala129 Ala129 Val130 Val130 130Leu131 Leu131 Gly132 Gly132 Lys133 Lys133 Val134 Val134 Asn135 Asn135 Leu136 Leu136 Ala137 Ala137 Gln138 Gln138 Leu139 Leu139 Val140 Val140 140Val141 Val141 Met142 Met142 Val143 Val143 Leu144 Leu144 Val145 Val145 Glu146 Glu146 Val147 Val147 Thr148 Thr148 Ala149 Ala149 Leu150 Leu150 150Gly151 Gly151 Asn152 Asn152 Leu153 Leu153 Arg154 Arg154 Met155 Met155 Val156 Val156 Ile157 Ile157 Ser158 Ser158 Asn159 Asn159 Ile160 Ile160 160Phe161 Phe161 Asn162 Asn162 Thr163 Thr163 Asp164 Asp164 Tyr165 Tyr165 His166 His166 Met167 Met167 Asn168 Asn168 Met169 Met169 Met170 Met170 170His171 His171 Ile172 Ile172 Tyr173 Tyr173 Val174 Val174 Phe175 Phe175 Ala176 Ala176 Ala177 Ala177 Tyr178 Tyr178 Phe179 Phe179 Gly180 Gly180 180Leu181 Leu181 Ser182 Ser182 Val183 Val183 Ala184 Ala184 Trp185 Trp185 Cys186 Cys186 Leu187 Leu187 Pro188 Pro188 Lys189 Lys189 Pro190 Pro190 190Leu191 Leu191 Pro192 Pro192 Glu193 Glu193 Gly194 Gly194 Thr195 Thr195 Glu196 Glu196 Asp197 Asp197 Lys198 Lys198 Asp199 Asp199 Gln200 Gln200 200Thr201 Thr201 Ala202 Ala202 Thr203 Thr203 Ile204 Ile204 Pro205 Pro205 Ser206 Ser206 Leu207 Leu207 Ser208 Ser208 Ala209 Ala209 Met210 Met210 210Leu211 Leu211 Gly212 Gly212 Ala213 Ala213 Leu214 Leu214 Phe215 Phe215 Leu216 Leu216 Trp217 Trp217 Met218 Met218 Phe219 Phe219 Trp220 Trp220 220Pro221 Pro221 Ser222 Ser222 Phe223 Phe223 Asn224 Asn224 Ser225 Ser225 Ala226 Ala226 Leu227 Leu227 Leu228 Leu228 Arg229 Arg229 Ser230 Ser230 230Pro231 Pro231 Ile232 Ile232 Glu233 Glu233 Arg234 Arg234 Lys235 Lys235 Asn236 Asn236 Ala237 Ala237 Val238 Val238 Phe239 Phe239 Asn240 Asn240 240Thr241 Thr241 Tyr242 Tyr242 Tyr243 Tyr243 Ala244 Ala244 Val245 Val245 Ala246 Ala246 Val247 Val247 Ser248 Ser248 Val249 Val249 Val250 Val250 250Thr251 Thr251 Ala252 Ala252 Ile253 Ile253 Ser254 Ser254 Gly255 Gly255 Ser256 Ser256 Ser257 Ser257 Leu258 Leu258 Ala259 Ala259 His260 His260 260Pro261 Pro261 Gln262 Gln262 Gly263 Gly263 Lys264 Lys264 Ile265 Ile265 Ser266 Ser266 Lys267 Lys267 Thr268 Thr268 Tyr269 Tyr269 Val270 Val270 270His271 His271 Ser272 Ser272 Ala273 Ala273 Val274 Val274 Leu275 Leu275 Ala276 Ala276 Gly277 Gly277 Gly278 Gly278 Val279 Val279 Ala280 Ala280 280Val281 Val281 Gly282 Gly282 Thr283 Thr283 Ser284 Ser284 Cys285 Cys285 His286 His286 Leu287 Leu287 Ile288 Ile288 Pro289 Pro289 Ser290 Ser290 290Pro291 Pro291 Trp292 Trp292 Leu293 Leu293 Ala294 Ala294 Met295 Met295 Val296 Val296 Leu297 Leu297 Gly298 Gly298 Leu299 Leu299 Val300 Val300 300Ala301 Ala301 Gly302 Gly302 Leu303 Leu303 Ile304 Ile304 Ser305 Ser305 Val306 Val306 Gly307 Gly307 Gly308 Gly308 Ala309 Ala309 Lys310 Lys310 310Tyr311 Tyr311 Leu312 Leu312 Pro313 Pro313 Gly314 Gly314 Cys315 Cys315 Cys316 Cys316 Asn317 Asn317 Arg318 Arg318 Val319 Val319 Leu320 Leu320 320Gly321 Gly321 Ile322 Ile322 Pro323 Pro323 His324 His324 Ser325 Ser325 Ser326 Ser326 Ile327 Ile327 Met328 Met328 Gly329 Gly329 Tyr330 Tyr330 330Asn331 Asn331 Phe332 Phe332 Ser333 Ser333 Leu334 Leu334 Leu335 Leu335 Gly336 Gly336 Leu337 Leu337 Leu338 Leu338 Gly339 Gly339 Glu340 Glu340 340Ile341 Ile341 Ile342 Ile342 Tyr343 Tyr343 Ile344 Ile344 Val345 Val345 Leu346 Leu346 Leu347 Leu347 Val348 Val348 Leu349 Leu349 Asp350 Asp350 350Thr351 Thr351 Val352 Val352 Gly353 Gly353 Ala354 Ala354 Gly355 Gly355 Asn356 Asn356 Gly357 Gly357 Met358 Met358 Ile359 Ile359 Gly360 Gly360 360Phe361 Phe361 Gln362 Gln362 Val363 Val363 Leu364 Leu364 Leu365 Leu365 Ser366 Ser366 Ile367 Ile367 Gly368 Gly368 Glu369 Glu369 Leu370 Leu370 370Ser371 Ser371 Leu372 Leu372 Ala373 Ala373 Ile374 Ile374 Val375 Val375 Ile376 Ile376 Ala377 Ala377 Leu378 Leu378 Met379 Met379 Ser380 Ser380 380Gly381 Gly381 Leu382 Leu382 Leu383 Leu383 Thr384 Thr384 Gly385 Gly385 Leu386 Leu386 Leu387 Leu387 Leu388 Leu388 Asn389 Asn389 Leu390 Leu390 390Lys391 Lys391 Ile392 Ile392 Trp393 Trp393 Lys394 Lys394 Ala395 Ala395 Pro396 Pro396 His397 His397 Glu398 Glu398 Ala399 Ala399 Lys400 Lys400 400Tyr401 Tyr401 Phe402 Phe402 Asp403 Asp403 Asp404 Asp404 Gln405 Gln405 Val406 Val406 Phe407 Phe407 Trp408 Trp408 Lys409 Lys409 Phe410 Phe410 410Pro411 Pro411 His412 His412 Leu413 Leu413 Ala414 Ala414 Val415 Val415 Gly416 Gly416 Phe417 Phe417 417 MSSKYPRSVRRCLPLWALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDLTVMAAIGLGFLTSSFRRHSWSSVAFNLFMLALGVQWAILLDGFLSQFPSGKVVITLFSIRLATMSALSVLISVDAVLGKVNLAQLVVMVLVEVTALGNLRMVISNIFNTDYHMNMMHIYVFAAYFGLSVAWCLPKPLPEGTEDKDQTATIPSLSAMLGALFLWMFWPSFNSALLRSPIERKNAVFNTYYAVAVSVVTAISGSSLAHPQGKISKTYVHSAVLAGGVAVGTSCHLIPSPWLAMVLGLVAGLISVGGAKYLPGCCNRVLGIPHSSIMGYNFSLLGLLGEIIYIVLLVLDTVGAGNGMIGFQVLLSIGELSLAIVIALMSGLLTGLLLNLKIWKAPHEAKYFDDQVFWKFPHLAVGF MSSKYPRSVRRCLPLWALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDLTVMAAIGLGFLTSSFRRHSWSSVAFNLFMLALGVQWAILLDGFLSQFPSGKVVITLFSIRLATMSALSVLISVDAVLGKVNLAQLVVMVLVEVTALGNLRMVISNIFNTDYHMNMMHIYVFAAYFGLSVAWCLPKPLPEGTEDKDQTATIPSLSAMLGALFLWMFWPSFNSALLRSPIERKNAVFNTYYAVAVSVVTAISGSSLAHPQGKISKTYVHSAVLAGGVAVGTSCHLIPSPWLAMVLGLVAGLISVGGAKYLPGCCNRVLGIPHSSIMGYNFSLLGLLGEIIYIVLLVLDTVGAGNGMIGFQVLLSIGELSLAIVIALMSGLLTGLLLNLKIWKAPHEAKYFDDQVFWKFPHLAVGF MSSKYPRSVRRCLPLWALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDLTVMAAIGLGFLTSSFRRHSWSSVAFNLFMLALGVQWAILLDGFLSQFPSGKVVITLFSIRLATMSALSVLISVDAVLGKVNLAQLVVMVLVEVTALGNLRMVISNIFNTDYHMNMMHIYVFAAYFGLSVAWCLPKPLPEGTEDKDQTATIPSLSAMLGALFLWMFWPSFNSALLRSPIERKNAVFNTYYAVAVSVVTAISGSSLAHPQGKISKTYVHSAVLAGGVAVGTSCHLIPSPWLAMVLGLVAGLISVGGAKYLPGCCNRVLGIPHSSIMGYNFSLLGLLGEIIYIVLLVLDTVGAGNGMIGFQVLLSIGELSLAIVIALMSGLLTGLLLNLKIWKAPHEAKYFDDQVFWKFPHLAVGF MSSKYPRSVRRCLPLWALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDLTVMAAIGLGFLTSSFRRHSWSSVAFNLFMLALGVQWAILLDGFLSQFPSGKVVITLFSIRLATMSALSVLISVDAVLGKVNLAQLVVMVLVEVTALGNLRMVISNIFNTDYHMNMMHIYVFAAYFGLSVAWCLPKPLPEGTEDKDQTATIPSLSAMLGALFLWMFWPSFNSALLRSPIERKNAVFNTYYAVAVSVVTAISGSSLAHPQGKISKTYVHSAVLAGGVAVGTSCHLIPSPWLAMVLGLVAGLISVGGAKYLPGCCNRVLGIPHSSIMGYNFSLLGLLGEIIYIVLLVLDTVGAGNGMIGFQVLLSIGELSLAIVIALMSGLLTGLLLNLKIWKAPHEAKYFDDQVFWKFPHLAVGF

Structure mapping

Movement    Mouse Input    Touch Input
RotationPrimary Mouse ButtonSingle touch
TranslationMiddle Mouse Button or Ctrl+PrimaryTriple touch
ZoomScroll Wheel or Second Mouse Button or Shift+PrimaryPinch (double touch)
SlabCtrl+SecondNot Available

Links

The Human RhesusBase The Human RhesusBase The Human RhesusBase
Genbank: S83379 AJ633649 AJ633650 AJ633651
Erythrogene

References

  1. International Society of Blood Transfusion et al. International Society of Blood Transfusion (ISBT) allele table Online ressource, 1935. — Online ressource — [RHeference]
  2. Hyland CA et al. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes. Blood, 1994. [Citation] [RHeference]
  3. Huang CH et al. Alteration of RH gene structure and expression in human dCCee and DCW-red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood, 1996. [Citation] [RHeference]
  4. Andrews KT et al. The RhD- trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood, 1998. [Citation] [RHeference]
  5. Wagner FF et al. RHD positive haplotypes in D negative Europeans. BMC Genet, 2001. [Citation] [RHeference]
  6. Shao CP et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang, 2002. [Citation] [RHeference]
  7. Peng CT et al. Molecular basis for the RhD negative phenotype in Chinese. Int J Mol Med, 2003. [Citation] [RHeference]
  8. Xu Q et al. Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene. Vox Sang, 2005. [Citation] [RHeference]
  9. Kim JY et al. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion, 2005. [Citation] [RHeference]
  10. Gassner C et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion, 2005. [Citation] [RHeference]
  11. Luettringhaus TA et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion, 2006. [Citation] [RHeference]
  12. Ye LY et al. Molecular and family analyses revealed two novel RHD alleles in a survey of a Chinese RhD-negative population. Vox Sang, 2007. [Citation] [RHeference]
  13. Pereira JC et al. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience. Prenat Diagn, 2007. [Citation] [RHeference]
  14. Nogues N et al. RHD null alleles in the Spanish population Vox Sanguinis, 2007. — Abstract — [RHeference]
  15. Polin H et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion, 2009. [Citation] [RHeference]
  16. J. Pereira et al. RHD Null Alleles in the Portuguese Population Transfusion Medicine, 2009. — Abstract — [RHeference]
  17. Ye L et al. Molecular bases of unexpressed RHD alleles in Chinese D- persons. Transfusion, 2009. [Citation] [RHeference]
  18. Wagner FF and Flegel WA et al. The Human RhesusBase Online ressource, 2011. — Online ressource — [RHeference]
  19. Krog GR et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion, 2011. [Citation] [RHeference]
  20. Cruz BR et al. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med, 2012. [Citation] [RHeference]
  21. Mota M et al. RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA. J Clin Lab Anal, 2012. [Citation] [RHeference]
  22. Orzińska A et al. RHD variants in Polish blood donors routinely typed as D-. Transfusion, 2013. [Citation] [RHeference]
  23. Gowland P et al. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci, 2014. [Citation] [RHeference]
  24. Ye SH et al. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an. Blood Transfus, 2014. [Citation] [RHeference]
  25. Trucco Boggione C et al. Molecular structures identified in serologically D- samples of an admixed population. Transfusion, 2014. [Citation] [RHeference]
  26. Scott SA et al. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes. Transfusion, 2014. [Citation] [RHeference]
  27. Crottet SL et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci, 2014. [Citation] [RHeference]
  28. Ogasawara K et al. Molecular basis for D- Japanese: identification of novel DEL and D- alleles. Vox Sang, 2015. [Citation] [RHeference]
  29. Stegmann TC et al. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol, 2016. [Citation] [RHeference]
  30. Hyland CA et al. Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types. Pathology, 2017. [Citation] [RHeference]
  31. Ji YL et al. RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay. Vox Sang, 2017. [Citation] [RHeference]
  32. Boggione CT et al. Genotyping approach for non-invasive foetal RHD detection in an admixed population. Blood Transfus, 2017. [Citation] [RHeference]
  33. Kulkarni SS et al. RHD-Positive Alleles among D- C/E+ Individuals from India. Transfus Med Hemother, 2018. [Citation] [RHeference]
  34. Jérôme Babinet et al. Erratum à l’article : « Résumés des Posters » [Transfus. Clin. Biol. 24 (2017) 3S] Transfusion Clinique et Biologique, 2018. — Abstract — [RHeference]
  35. Izaskun Apraiz et al. Performance Evaluation Study of ID RHD XT as a Molecular Tool for RHD Gene Screening in Pooled Blood Samples of Serologically D− C/E+ Donors Transfusion, 2019. — Abstract — [RHeference]
  36. Zhang X et al. Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China. J Transl Med, 2019. [Citation] [RHeference]
  37. Richard Garrett et al. Novel RHD-CE-D Hybrid Allele Associated With D- C+ Phenotype Transfusion, 2019. — Abstract — [RHeference]
  38. Trucco Boggione C et al. Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion, 2019. [Citation] [RHeference]
  39. Guzijan G et al. Implementation of Molecular RHD Typing at Two Blood Transfusion Institutes from Southeastern Europe. Transfus Med Hemother, 2019. [Citation] [RHeference]
  40. Perez-Alvarez I et al. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center. Transfusion, 2019. [Citation] [RHeference]
  41. Thongbut J et al. Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial D Phenotype in Thai Blood Donors. Transfus Med Hemother, 2020. [Citation] [RHeference]
  42. Stef M et al. RH genotyping by nonspecific quantitative next-generation sequencing. Transfusion, 2020. [Citation] [RHeference]
  43. Floch A et al. Comment from Rheference Online ressource, 2020. — Online ressource — [RHeference]
  44. Safic Stanic H et al. D variants in the population of D-negative blood donors in the north-eastern region of Croatia. Transfus Med, 2021. [Citation] [RHeference]

Last update: Jan. 8, 2021